The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men

European Journal of Endocrinology

Volumn 152, Issue 4, 2005, Pages 575-580

  Haijma, Sander V ^a   Stytze van Dam, P ^a,b   de Vries, Wouter R ^a   Maitimu Smeele, Inge ^a   Dieguez, Carlos ^c   Casanueva, Felipe F ^a   Koppeschaar, Hans P F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE SEVERITY; GERIATRIC PATIENT; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGING; BODY MASS INDEX; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, INTRAVENOUS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OBESITY; OLIGOPEPTIDES;

EID: 17744369702     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01887     Document Type: Article

References (31)

1. Cordido F, Penalva A, Peino R, Casanueva FF & Dieguez C. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects. Metabolism 1995 44 745-748.
2. Arvat E, Gianotti L, Grottoli S, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F & Ghigo E. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. Journal of Clinical Endocrinology and Metabolism 1994 79 1440-1443.
3. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML & Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. Journal of Clinical Endocrinology and Metabolism 1991 72 51-59.
4. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA & Bain RP. Impaired growth hormone secretion in the adult population: relation to age and adiposity. Journal of Clinical Investigation 1981 67 1361-1369.
5. Frystyk J, Vestbo E, Skjaerback C, Mogensen CE & Orskov H. Free insulin-like growth factors in human obesity. Metabolism 1995 44 S37-S44.
6. Cordido F, Casanueva FF, Vidal JI & Dieguez C. Study of insulin-like growth factor I in human obesity. Hormone Research 1991 36 187-191.
7. Copeland KC, Colletti RB, Devlin JT & McAuliffe TL. The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism 1990 39 584-587.
8. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T & Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395.
9. Corpas E, Harman SM & Blackman MR. Human growth hormone and human aging. Endocrine Reviews 1993 14 20-39.
10. Toogood AA, Adams JE, O'Neill PA & Shalet SM. Body composition in growth hormone deficient adults over the age of 60 years. Clinical Endocrinology 1996 45 399-405.
11. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S & Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metabolism Research and Reviews 1999 15 314-322.
12. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism 1998 83 379-381.
13. Hoeck HC, Vestergaard P, Jakobsen PE & Laurberg P. Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. European Journal of Endocrinology 1995 133 305-312.
14. Popovic V, Leal A, Micic D, Koppeschaar HPF, Torres E, Paramo C, Obradovic S, Dieguez C & Casanueva FF. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet 2000 356 1137-1142.
15. Bowers CY. Synergistic release of growth hormone by GHRP and GHRH: scope and implication. In Growth Hormone Secretagogues in Clinical Practice, pp 1-25. Eds BB Bercu & RF Walker. New York: Marcel Dekker, 1998.
16. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo M & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660.
17. Potersenn S, Jung R & Beil FU. Diagnosis of growth hormone deficiency in adults by testing with GHRP-6 alone or in combination with GHRH: comparison with the insulin tolerance test. European Journal of Endocrinology 2002 146 667-672.
18. Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF & Dieguez C. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. European Journal of Endocrinology 2003 149 117-122.
19. Ozata M, Dieguez C & Casanueva FF. The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels: a study in human leptin deficiency patients. Journal of Clinical Endocrinology and Metabolism 2003 88 312-316.
20. Popovic V, Pekic S, Doknic M, Micic D, Damjanovic S, Zarkovic M, Aimaretti G, Corneli G, Ghigo E, Deiguez C & Casanueva FF. The effectiveness of arginine+GHRH test compared with GHRH + GHRP-6 test in diagnosing growth hormone deficiency in adults. Clinical Endocrinology 2003 59 251-257.
21. de Vries BB, Robinson H, Stolte-Dijkstra I, Tjon Pian Gi CV, Dijkstra PF, van Doorn J, Halley DJ, Oostra BA, Turner G & Niermeijer MF. General overgrowth in the fragile X syndrome: variability in the phenotypic expression of the FMR1 gene mutation. Journal of Medical Genetics 1995 32 764-769.
22. Cordido F, Dieguez C & Casanueva FF. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. Journal of Clinical Endocrinology and Metabolism 1990 70 1361-1370.
23. Cordido F, Fernandez T, Martinez T, Penalva A, Peino R, Casanueva FF & Dieguez C. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. Journal of Clinical Endocrinology and Metabolism 1998 83 4350-4354.
24. Toogood AA, Adams JE, O'Neill PA & Shalet SM. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. Journal of Clinical Endocrinology and Metabolism 1997 82 1462-1466.
25. Toogood AA, Jones J, O'Neill PA, Thorner MO & Shalet SM. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease. Clinical Endocrinology 1998 48 569-576.
26. Lanzi R, Manzoni MF, Andreotti AC, Malighetti ME, Bianchi E, Sereni LP, Caumo A, Luzi L & Pontiroli AE. Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone (GH) response to GH-releasing hormone in healthy subjects. Journal of Clinical Endocrinology and Metabolism 1997 82 2239-2243.
27. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E & Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 707-709.
28. Casanueva FF, Villanueva L, Dieguez C, Diaz Y, Cabranes JA, Szoke B, Scanlon MF, Schally AV & Fernandez Cruz A. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. Journal of Clinical Endocrinology and Metabolism 1987 65 634-642.
29. Tannenbaum GS, Lapointe M, Gurd W & Finkelstein JA. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin. Endocrinology 1990 127 3087-3095.
30. Ghigo E, Procopio M, Maccario M, Bellone J, Arvat E, Campana S, Boghen MF & Camanni F. Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity? Hormone and Metabolic Research 1993 25 305-308.
31. Cordido F, Casanueva FF & Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. Journal of Clinical Endocrinology and Metabolism 1989 68 290-293.